Cardiovascular disease screening
Cardiovascular disease is the leading cause of death amongst women worldwide. Cardiovascular risk assessment and primary prevention are important strategies to improve morbidity and mortality. In additional to the traditional risk factors, pregnancy complications such as pre-eclampsia and gestationa...
Ausführliche Beschreibung
Autor*in: |
Duffy, Jennifer Y. [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2015transfer abstract |
---|
Schlagwörter: |
---|
Umfang: |
4 |
---|
Übergeordnetes Werk: |
Enthalten in: Dissociating patterns of anterior and posterior hippocampal activity and connectivity during distinct forms of category fluency - Sheldon, Signy ELSEVIER, 2016transfer abstract, Philadelphia, Pa |
---|---|
Übergeordnetes Werk: |
volume:39 ; year:2015 ; number:4 ; pages:264-267 ; extent:4 |
Links: |
---|
DOI / URN: |
10.1053/j.semperi.2015.05.004 |
---|
Katalog-ID: |
ELV034379878 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV034379878 | ||
003 | DE-627 | ||
005 | 20230625200741.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180603s2015 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1053/j.semperi.2015.05.004 |2 doi | |
028 | 5 | 2 | |a GBVA2015003000014.pica |
035 | |a (DE-627)ELV034379878 | ||
035 | |a (ELSEVIER)S0146-0005(15)00039-7 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | |a 610 | |
082 | 0 | 4 | |a 610 |q DE-600 |
082 | 0 | 4 | |a 610 |q VZ |
082 | 0 | 4 | |a 610 |q VZ |
084 | |a 44.71 |2 bkl | ||
100 | 1 | |a Duffy, Jennifer Y. |e verfasserin |4 aut | |
245 | 1 | 0 | |a Cardiovascular disease screening |
264 | 1 | |c 2015transfer abstract | |
300 | |a 4 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a Cardiovascular disease is the leading cause of death amongst women worldwide. Cardiovascular risk assessment and primary prevention are important strategies to improve morbidity and mortality. In additional to the traditional risk factors, pregnancy complications such as pre-eclampsia and gestational diabetes increment future risk of developing cardiovascular complications. Additionally, several serum biomarkers are valuable measures for both risk assessment and predictors of clinical outcomes in women. The purpose of this review is to describe current risk stratification schemes as well as outline the role of obstetric history and serum biomarkers in adjusting risk stratification in women. | ||
520 | |a Cardiovascular disease is the leading cause of death amongst women worldwide. Cardiovascular risk assessment and primary prevention are important strategies to improve morbidity and mortality. In additional to the traditional risk factors, pregnancy complications such as pre-eclampsia and gestational diabetes increment future risk of developing cardiovascular complications. Additionally, several serum biomarkers are valuable measures for both risk assessment and predictors of clinical outcomes in women. The purpose of this review is to describe current risk stratification schemes as well as outline the role of obstetric history and serum biomarkers in adjusting risk stratification in women. | ||
650 | 7 | |a CVD |2 Elsevier | |
650 | 7 | |a pregnancy |2 Elsevier | |
650 | 7 | |a CVD prevention |2 Elsevier | |
650 | 7 | |a Cardiovascular health |2 Elsevier | |
700 | 1 | |a Hameed, Afshan B. |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Saunders |a Sheldon, Signy ELSEVIER |t Dissociating patterns of anterior and posterior hippocampal activity and connectivity during distinct forms of category fluency |d 2016transfer abstract |g Philadelphia, Pa |w (DE-627)ELV019924089 |
773 | 1 | 8 | |g volume:39 |g year:2015 |g number:4 |g pages:264-267 |g extent:4 |
856 | 4 | 0 | |u https://doi.org/10.1053/j.semperi.2015.05.004 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a SSG-OLC-PHA | ||
936 | b | k | |a 44.71 |j Verkehrsmedizin |q VZ |
951 | |a AR | ||
952 | |d 39 |j 2015 |e 4 |h 264-267 |g 4 | ||
953 | |2 045F |a 610 |
author_variant |
j y d jy jyd |
---|---|
matchkey_str |
duffyjenniferyhameedafshanb:2015----:adoaclries |
hierarchy_sort_str |
2015transfer abstract |
bklnumber |
44.71 |
publishDate |
2015 |
allfields |
10.1053/j.semperi.2015.05.004 doi GBVA2015003000014.pica (DE-627)ELV034379878 (ELSEVIER)S0146-0005(15)00039-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.71 bkl Duffy, Jennifer Y. verfasserin aut Cardiovascular disease screening 2015transfer abstract 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Cardiovascular disease is the leading cause of death amongst women worldwide. Cardiovascular risk assessment and primary prevention are important strategies to improve morbidity and mortality. In additional to the traditional risk factors, pregnancy complications such as pre-eclampsia and gestational diabetes increment future risk of developing cardiovascular complications. Additionally, several serum biomarkers are valuable measures for both risk assessment and predictors of clinical outcomes in women. The purpose of this review is to describe current risk stratification schemes as well as outline the role of obstetric history and serum biomarkers in adjusting risk stratification in women. Cardiovascular disease is the leading cause of death amongst women worldwide. Cardiovascular risk assessment and primary prevention are important strategies to improve morbidity and mortality. In additional to the traditional risk factors, pregnancy complications such as pre-eclampsia and gestational diabetes increment future risk of developing cardiovascular complications. Additionally, several serum biomarkers are valuable measures for both risk assessment and predictors of clinical outcomes in women. The purpose of this review is to describe current risk stratification schemes as well as outline the role of obstetric history and serum biomarkers in adjusting risk stratification in women. CVD Elsevier pregnancy Elsevier CVD prevention Elsevier Cardiovascular health Elsevier Hameed, Afshan B. oth Enthalten in Saunders Sheldon, Signy ELSEVIER Dissociating patterns of anterior and posterior hippocampal activity and connectivity during distinct forms of category fluency 2016transfer abstract Philadelphia, Pa (DE-627)ELV019924089 volume:39 year:2015 number:4 pages:264-267 extent:4 https://doi.org/10.1053/j.semperi.2015.05.004 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.71 Verkehrsmedizin VZ AR 39 2015 4 264-267 4 045F 610 |
spelling |
10.1053/j.semperi.2015.05.004 doi GBVA2015003000014.pica (DE-627)ELV034379878 (ELSEVIER)S0146-0005(15)00039-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.71 bkl Duffy, Jennifer Y. verfasserin aut Cardiovascular disease screening 2015transfer abstract 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Cardiovascular disease is the leading cause of death amongst women worldwide. Cardiovascular risk assessment and primary prevention are important strategies to improve morbidity and mortality. In additional to the traditional risk factors, pregnancy complications such as pre-eclampsia and gestational diabetes increment future risk of developing cardiovascular complications. Additionally, several serum biomarkers are valuable measures for both risk assessment and predictors of clinical outcomes in women. The purpose of this review is to describe current risk stratification schemes as well as outline the role of obstetric history and serum biomarkers in adjusting risk stratification in women. Cardiovascular disease is the leading cause of death amongst women worldwide. Cardiovascular risk assessment and primary prevention are important strategies to improve morbidity and mortality. In additional to the traditional risk factors, pregnancy complications such as pre-eclampsia and gestational diabetes increment future risk of developing cardiovascular complications. Additionally, several serum biomarkers are valuable measures for both risk assessment and predictors of clinical outcomes in women. The purpose of this review is to describe current risk stratification schemes as well as outline the role of obstetric history and serum biomarkers in adjusting risk stratification in women. CVD Elsevier pregnancy Elsevier CVD prevention Elsevier Cardiovascular health Elsevier Hameed, Afshan B. oth Enthalten in Saunders Sheldon, Signy ELSEVIER Dissociating patterns of anterior and posterior hippocampal activity and connectivity during distinct forms of category fluency 2016transfer abstract Philadelphia, Pa (DE-627)ELV019924089 volume:39 year:2015 number:4 pages:264-267 extent:4 https://doi.org/10.1053/j.semperi.2015.05.004 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.71 Verkehrsmedizin VZ AR 39 2015 4 264-267 4 045F 610 |
allfields_unstemmed |
10.1053/j.semperi.2015.05.004 doi GBVA2015003000014.pica (DE-627)ELV034379878 (ELSEVIER)S0146-0005(15)00039-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.71 bkl Duffy, Jennifer Y. verfasserin aut Cardiovascular disease screening 2015transfer abstract 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Cardiovascular disease is the leading cause of death amongst women worldwide. Cardiovascular risk assessment and primary prevention are important strategies to improve morbidity and mortality. In additional to the traditional risk factors, pregnancy complications such as pre-eclampsia and gestational diabetes increment future risk of developing cardiovascular complications. Additionally, several serum biomarkers are valuable measures for both risk assessment and predictors of clinical outcomes in women. The purpose of this review is to describe current risk stratification schemes as well as outline the role of obstetric history and serum biomarkers in adjusting risk stratification in women. Cardiovascular disease is the leading cause of death amongst women worldwide. Cardiovascular risk assessment and primary prevention are important strategies to improve morbidity and mortality. In additional to the traditional risk factors, pregnancy complications such as pre-eclampsia and gestational diabetes increment future risk of developing cardiovascular complications. Additionally, several serum biomarkers are valuable measures for both risk assessment and predictors of clinical outcomes in women. The purpose of this review is to describe current risk stratification schemes as well as outline the role of obstetric history and serum biomarkers in adjusting risk stratification in women. CVD Elsevier pregnancy Elsevier CVD prevention Elsevier Cardiovascular health Elsevier Hameed, Afshan B. oth Enthalten in Saunders Sheldon, Signy ELSEVIER Dissociating patterns of anterior and posterior hippocampal activity and connectivity during distinct forms of category fluency 2016transfer abstract Philadelphia, Pa (DE-627)ELV019924089 volume:39 year:2015 number:4 pages:264-267 extent:4 https://doi.org/10.1053/j.semperi.2015.05.004 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.71 Verkehrsmedizin VZ AR 39 2015 4 264-267 4 045F 610 |
allfieldsGer |
10.1053/j.semperi.2015.05.004 doi GBVA2015003000014.pica (DE-627)ELV034379878 (ELSEVIER)S0146-0005(15)00039-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.71 bkl Duffy, Jennifer Y. verfasserin aut Cardiovascular disease screening 2015transfer abstract 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Cardiovascular disease is the leading cause of death amongst women worldwide. Cardiovascular risk assessment and primary prevention are important strategies to improve morbidity and mortality. In additional to the traditional risk factors, pregnancy complications such as pre-eclampsia and gestational diabetes increment future risk of developing cardiovascular complications. Additionally, several serum biomarkers are valuable measures for both risk assessment and predictors of clinical outcomes in women. The purpose of this review is to describe current risk stratification schemes as well as outline the role of obstetric history and serum biomarkers in adjusting risk stratification in women. Cardiovascular disease is the leading cause of death amongst women worldwide. Cardiovascular risk assessment and primary prevention are important strategies to improve morbidity and mortality. In additional to the traditional risk factors, pregnancy complications such as pre-eclampsia and gestational diabetes increment future risk of developing cardiovascular complications. Additionally, several serum biomarkers are valuable measures for both risk assessment and predictors of clinical outcomes in women. The purpose of this review is to describe current risk stratification schemes as well as outline the role of obstetric history and serum biomarkers in adjusting risk stratification in women. CVD Elsevier pregnancy Elsevier CVD prevention Elsevier Cardiovascular health Elsevier Hameed, Afshan B. oth Enthalten in Saunders Sheldon, Signy ELSEVIER Dissociating patterns of anterior and posterior hippocampal activity and connectivity during distinct forms of category fluency 2016transfer abstract Philadelphia, Pa (DE-627)ELV019924089 volume:39 year:2015 number:4 pages:264-267 extent:4 https://doi.org/10.1053/j.semperi.2015.05.004 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.71 Verkehrsmedizin VZ AR 39 2015 4 264-267 4 045F 610 |
allfieldsSound |
10.1053/j.semperi.2015.05.004 doi GBVA2015003000014.pica (DE-627)ELV034379878 (ELSEVIER)S0146-0005(15)00039-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.71 bkl Duffy, Jennifer Y. verfasserin aut Cardiovascular disease screening 2015transfer abstract 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Cardiovascular disease is the leading cause of death amongst women worldwide. Cardiovascular risk assessment and primary prevention are important strategies to improve morbidity and mortality. In additional to the traditional risk factors, pregnancy complications such as pre-eclampsia and gestational diabetes increment future risk of developing cardiovascular complications. Additionally, several serum biomarkers are valuable measures for both risk assessment and predictors of clinical outcomes in women. The purpose of this review is to describe current risk stratification schemes as well as outline the role of obstetric history and serum biomarkers in adjusting risk stratification in women. Cardiovascular disease is the leading cause of death amongst women worldwide. Cardiovascular risk assessment and primary prevention are important strategies to improve morbidity and mortality. In additional to the traditional risk factors, pregnancy complications such as pre-eclampsia and gestational diabetes increment future risk of developing cardiovascular complications. Additionally, several serum biomarkers are valuable measures for both risk assessment and predictors of clinical outcomes in women. The purpose of this review is to describe current risk stratification schemes as well as outline the role of obstetric history and serum biomarkers in adjusting risk stratification in women. CVD Elsevier pregnancy Elsevier CVD prevention Elsevier Cardiovascular health Elsevier Hameed, Afshan B. oth Enthalten in Saunders Sheldon, Signy ELSEVIER Dissociating patterns of anterior and posterior hippocampal activity and connectivity during distinct forms of category fluency 2016transfer abstract Philadelphia, Pa (DE-627)ELV019924089 volume:39 year:2015 number:4 pages:264-267 extent:4 https://doi.org/10.1053/j.semperi.2015.05.004 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.71 Verkehrsmedizin VZ AR 39 2015 4 264-267 4 045F 610 |
language |
English |
source |
Enthalten in Dissociating patterns of anterior and posterior hippocampal activity and connectivity during distinct forms of category fluency Philadelphia, Pa volume:39 year:2015 number:4 pages:264-267 extent:4 |
sourceStr |
Enthalten in Dissociating patterns of anterior and posterior hippocampal activity and connectivity during distinct forms of category fluency Philadelphia, Pa volume:39 year:2015 number:4 pages:264-267 extent:4 |
format_phy_str_mv |
Article |
bklname |
Verkehrsmedizin |
institution |
findex.gbv.de |
topic_facet |
CVD pregnancy CVD prevention Cardiovascular health |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
Dissociating patterns of anterior and posterior hippocampal activity and connectivity during distinct forms of category fluency |
authorswithroles_txt_mv |
Duffy, Jennifer Y. @@aut@@ Hameed, Afshan B. @@oth@@ |
publishDateDaySort_date |
2015-01-01T00:00:00Z |
hierarchy_top_id |
ELV019924089 |
dewey-sort |
3610 |
id |
ELV034379878 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV034379878</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625200741.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1053/j.semperi.2015.05.004</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015003000014.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV034379878</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0146-0005(15)00039-7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.71</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Duffy, Jennifer Y.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cardiovascular disease screening</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">4</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Cardiovascular disease is the leading cause of death amongst women worldwide. Cardiovascular risk assessment and primary prevention are important strategies to improve morbidity and mortality. In additional to the traditional risk factors, pregnancy complications such as pre-eclampsia and gestational diabetes increment future risk of developing cardiovascular complications. Additionally, several serum biomarkers are valuable measures for both risk assessment and predictors of clinical outcomes in women. The purpose of this review is to describe current risk stratification schemes as well as outline the role of obstetric history and serum biomarkers in adjusting risk stratification in women.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Cardiovascular disease is the leading cause of death amongst women worldwide. Cardiovascular risk assessment and primary prevention are important strategies to improve morbidity and mortality. In additional to the traditional risk factors, pregnancy complications such as pre-eclampsia and gestational diabetes increment future risk of developing cardiovascular complications. Additionally, several serum biomarkers are valuable measures for both risk assessment and predictors of clinical outcomes in women. The purpose of this review is to describe current risk stratification schemes as well as outline the role of obstetric history and serum biomarkers in adjusting risk stratification in women.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CVD</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">pregnancy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CVD prevention</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cardiovascular health</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hameed, Afshan B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Saunders</subfield><subfield code="a">Sheldon, Signy ELSEVIER</subfield><subfield code="t">Dissociating patterns of anterior and posterior hippocampal activity and connectivity during distinct forms of category fluency</subfield><subfield code="d">2016transfer abstract</subfield><subfield code="g">Philadelphia, Pa</subfield><subfield code="w">(DE-627)ELV019924089</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:39</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:4</subfield><subfield code="g">pages:264-267</subfield><subfield code="g">extent:4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1053/j.semperi.2015.05.004</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.71</subfield><subfield code="j">Verkehrsmedizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">39</subfield><subfield code="j">2015</subfield><subfield code="e">4</subfield><subfield code="h">264-267</subfield><subfield code="g">4</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
author |
Duffy, Jennifer Y. |
spellingShingle |
Duffy, Jennifer Y. ddc 610 bkl 44.71 Elsevier CVD Elsevier pregnancy Elsevier CVD prevention Elsevier Cardiovascular health Cardiovascular disease screening |
authorStr |
Duffy, Jennifer Y. |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV019924089 |
format |
electronic Article |
dewey-ones |
610 - Medicine & health |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
610 610 DE-600 610 VZ 44.71 bkl Cardiovascular disease screening CVD Elsevier pregnancy Elsevier CVD prevention Elsevier Cardiovascular health Elsevier |
topic |
ddc 610 bkl 44.71 Elsevier CVD Elsevier pregnancy Elsevier CVD prevention Elsevier Cardiovascular health |
topic_unstemmed |
ddc 610 bkl 44.71 Elsevier CVD Elsevier pregnancy Elsevier CVD prevention Elsevier Cardiovascular health |
topic_browse |
ddc 610 bkl 44.71 Elsevier CVD Elsevier pregnancy Elsevier CVD prevention Elsevier Cardiovascular health |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
a b h ab abh |
hierarchy_parent_title |
Dissociating patterns of anterior and posterior hippocampal activity and connectivity during distinct forms of category fluency |
hierarchy_parent_id |
ELV019924089 |
dewey-tens |
610 - Medicine & health |
hierarchy_top_title |
Dissociating patterns of anterior and posterior hippocampal activity and connectivity during distinct forms of category fluency |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV019924089 |
title |
Cardiovascular disease screening |
ctrlnum |
(DE-627)ELV034379878 (ELSEVIER)S0146-0005(15)00039-7 |
title_full |
Cardiovascular disease screening |
author_sort |
Duffy, Jennifer Y. |
journal |
Dissociating patterns of anterior and posterior hippocampal activity and connectivity during distinct forms of category fluency |
journalStr |
Dissociating patterns of anterior and posterior hippocampal activity and connectivity during distinct forms of category fluency |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology |
recordtype |
marc |
publishDateSort |
2015 |
contenttype_str_mv |
zzz |
container_start_page |
264 |
author_browse |
Duffy, Jennifer Y. |
container_volume |
39 |
physical |
4 |
class |
610 610 DE-600 610 VZ 44.71 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Duffy, Jennifer Y. |
doi_str_mv |
10.1053/j.semperi.2015.05.004 |
dewey-full |
610 |
title_sort |
cardiovascular disease screening |
title_auth |
Cardiovascular disease screening |
abstract |
Cardiovascular disease is the leading cause of death amongst women worldwide. Cardiovascular risk assessment and primary prevention are important strategies to improve morbidity and mortality. In additional to the traditional risk factors, pregnancy complications such as pre-eclampsia and gestational diabetes increment future risk of developing cardiovascular complications. Additionally, several serum biomarkers are valuable measures for both risk assessment and predictors of clinical outcomes in women. The purpose of this review is to describe current risk stratification schemes as well as outline the role of obstetric history and serum biomarkers in adjusting risk stratification in women. |
abstractGer |
Cardiovascular disease is the leading cause of death amongst women worldwide. Cardiovascular risk assessment and primary prevention are important strategies to improve morbidity and mortality. In additional to the traditional risk factors, pregnancy complications such as pre-eclampsia and gestational diabetes increment future risk of developing cardiovascular complications. Additionally, several serum biomarkers are valuable measures for both risk assessment and predictors of clinical outcomes in women. The purpose of this review is to describe current risk stratification schemes as well as outline the role of obstetric history and serum biomarkers in adjusting risk stratification in women. |
abstract_unstemmed |
Cardiovascular disease is the leading cause of death amongst women worldwide. Cardiovascular risk assessment and primary prevention are important strategies to improve morbidity and mortality. In additional to the traditional risk factors, pregnancy complications such as pre-eclampsia and gestational diabetes increment future risk of developing cardiovascular complications. Additionally, several serum biomarkers are valuable measures for both risk assessment and predictors of clinical outcomes in women. The purpose of this review is to describe current risk stratification schemes as well as outline the role of obstetric history and serum biomarkers in adjusting risk stratification in women. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
container_issue |
4 |
title_short |
Cardiovascular disease screening |
url |
https://doi.org/10.1053/j.semperi.2015.05.004 |
remote_bool |
true |
author2 |
Hameed, Afshan B. |
author2Str |
Hameed, Afshan B. |
ppnlink |
ELV019924089 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth |
doi_str |
10.1053/j.semperi.2015.05.004 |
up_date |
2024-07-06T20:58:29.262Z |
_version_ |
1803864778224959488 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV034379878</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625200741.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1053/j.semperi.2015.05.004</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015003000014.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV034379878</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0146-0005(15)00039-7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.71</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Duffy, Jennifer Y.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cardiovascular disease screening</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">4</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Cardiovascular disease is the leading cause of death amongst women worldwide. Cardiovascular risk assessment and primary prevention are important strategies to improve morbidity and mortality. In additional to the traditional risk factors, pregnancy complications such as pre-eclampsia and gestational diabetes increment future risk of developing cardiovascular complications. Additionally, several serum biomarkers are valuable measures for both risk assessment and predictors of clinical outcomes in women. The purpose of this review is to describe current risk stratification schemes as well as outline the role of obstetric history and serum biomarkers in adjusting risk stratification in women.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Cardiovascular disease is the leading cause of death amongst women worldwide. Cardiovascular risk assessment and primary prevention are important strategies to improve morbidity and mortality. In additional to the traditional risk factors, pregnancy complications such as pre-eclampsia and gestational diabetes increment future risk of developing cardiovascular complications. Additionally, several serum biomarkers are valuable measures for both risk assessment and predictors of clinical outcomes in women. The purpose of this review is to describe current risk stratification schemes as well as outline the role of obstetric history and serum biomarkers in adjusting risk stratification in women.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CVD</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">pregnancy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CVD prevention</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cardiovascular health</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hameed, Afshan B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Saunders</subfield><subfield code="a">Sheldon, Signy ELSEVIER</subfield><subfield code="t">Dissociating patterns of anterior and posterior hippocampal activity and connectivity during distinct forms of category fluency</subfield><subfield code="d">2016transfer abstract</subfield><subfield code="g">Philadelphia, Pa</subfield><subfield code="w">(DE-627)ELV019924089</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:39</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:4</subfield><subfield code="g">pages:264-267</subfield><subfield code="g">extent:4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1053/j.semperi.2015.05.004</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.71</subfield><subfield code="j">Verkehrsmedizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">39</subfield><subfield code="j">2015</subfield><subfield code="e">4</subfield><subfield code="h">264-267</subfield><subfield code="g">4</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
score |
7.3996973 |